01—History
Long-Term Debt History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2021–FY2026. Drag across the bars to change the range.
- $399.4M
4 older moves run past ±150% (largest +39014.2%); point at, tap or drag across the bars to read one.
02—Ledger
Long-Term Debt, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2026 | $399.4M | −39.3% | 10-K | |
| FY2025 | $658.4M | −5.6% | 10-K | |
| FY2024 | $697.3M | −51.3% | 10-K | |
| FY2023 | $1.43B | +87.0% | 10-K | |
| FY2022 | $765.3M | +19.0% | 10-K | |
| FY2021 | $643.4M | −44.7% | 10-K | |
| FY2020 | $1.16B | −7.5% | 10-K | |
| FY2019 | $1.26B | +366.3% | 10-K | |
| FY2018 | $270.0M | −75.0% | 10-K | |
| FY2017 | $1.08B | +23.5% | 10-K | |
| FY2016 | $873.3M | +190.5% | 10-K | |
| FY2015 | $300.6M | −0.1% | 10-K | |
| FY2014 | $300.8M | +39014.2% | 10-K | |
| FY2013 | $769,000 | −99.7% | 10-K | |
| FY2012 | $250.8M | +150.8% | 10-K | |
| FY2011 | $100.0M | — | 10-K | |
| FY2010 | $0 | — | 10-K |
03—Questions
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is ResMed's current long-term debt?
ResMed (RMD) annual long-term debt for 2026 was $399.4M, a 39.33% decline from 2025. ResMed long-term debt for the quarter ending September 30, 2026 was $249.6M.
What was ResMed's long-term debt in 2025?
ResMed annual long-term debt for 2025 was $658.4M, a 5.58% decline from 2024.
What was ResMed's long-term debt in 2024?
ResMed annual long-term debt for 2024 was $697.3M, a 51.28% decline from 2023.
What is ResMed's 5-year long-term debt CAGR?
ResMed long-term debt grew at a compound annual growth rate (CAGR) of 9.09% from FY2021 to FY2026, going from $643.4M to $399.4M over 5 years.
- Company
- ResMed
- Ticker
- RMD
- Sector
- Healthcare
- Industry
- Surgical & Medical Instruments & Apparatus